Bristol-Myers Squibb
Emergent
Regeneron
Novavax
Takeda
Allergan

Working Worldwide

Bioassay Sciences is targeted to serve the special needs of Bioassay Scientists globally. We work with the special needs of cell based potency assays, binding assays and animal assays to name a few. We have direct experience working with Vaccines, Antibodies, and other large molecule drug programs. Potency is one of the most important elements of a drug program as it directly links to clinical performance of the drug substance or drug product. We provide the method of calculation, validity criteria for relative potency, reportable results, outlier tests, equivalence testing and the associated assay validation and data management. Our SAS/JMP based platform for bioassays transcend the limitations of currently available off-the-shelf solutions.

Our clients directly benefit from putting their bioassays on our platform with reduced variation and a reduction in OOS and invalid rates.

List of Past and Current Clients

Emergent BioSolutions is a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland.[9] It develops vaccines and antibody therapeutics for infectious diseases, oncology and autoimmune disorders, and provides medical devices for biodefense purposes.
Covance Inc., a global contract research organization (CRO), is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real® by providing high-quality nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development.
Takeda's U.S. clinical development activities are conducted via Takeda Development Center Americas, Inc., which has a robust pipeline of compounds in multiple therapeutic areas including metabolic and cardiovascular diseases, central nervous system, respiratory and immunology, oncology and general medicine.
Allergan is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.

Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.
Novavax, Inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases.
Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases such as cancer, cardiovascular disease, hepatitis B and hepatitis C, HIV/AIDS and, rheumatoid arthritis.
Agensys, Inc., an affiliate of Astellas Pharma Inc., specializes in developing a pipeline of therapeutic fully human monoclonal antibodies (mAbs) to treat cancer. The mAb product pipeline is generated by Agensys’ diverse portfolio of proprietary, clinically relevant targets that encompass unmet clinical needs in cancer. Multiple programs are currently undergoing Phase I and Phase II Clinical Trials.

Agensys has full capabilities to generate, develop and manufacture antibody products. The company has been in operation since 1997 and was acquired by Astellas in December 2007. Agensys has over 200 employees, and is located in Santa Monica, California.
Regeneron has an extensive pipeline of investigational product candidates that are progressing through all stages of human clinical trials. Their product candidates address many serious medical conditions including cancer, eye diseases, inflammatory diseases, pain, cardiovascular diseases and allergic conditions.

Have a project for us?

Get in touch